<|begin_of_text|><|start_header_id|>system<|end_header_id|>You are an expert on climate change, human mobility and migration. Answer the question truthfully.<|eot_id|><|start_header_id|>user<|end_header_id|>Here are the title and abstract of a scientific paper probably related to climate change, human mobility and migration..
Title:"TREATMENT OF SCHISTOSOMA-MEKONGI WITH PRAZIQUANTEL - A DOUBLE-BLIND-STUDY."
Abstract:"Praziquantel is a newly developed drug effective in the treatment of schistosomiasis. To assess the efficacy and toxicity of praziquantel in the treatment of S. mekongi, 11 infected [human] Laotian refugees, all belonging to a single extended family, were treated in a double-blind crossover trial with praziquantel and placebo. Initially, 1 group of 5 received praziquantel 60 mg/kg body wt in 3 divided doses orally, while the remainder received an identically appearing placebo. Patients were evaluated clinically before, during and following therapy for 2 days. After 2.5 mo. the patients were reevaluated and subjected to the opposite treatment, and final follow-up took place 5-7 mo. later. Three other patients were treated using an open protocol. All but 1 person was cured (91%). This patient failed to show a decrease in egg excretion 2.5 wk after praziquantel therapy and was lost to follow-up thereafter. Side effects were common and consisted primarily of abdominal pain, malaise and fever. These were generaly mild and transient. No abnormal laboratory findings were associated with praziquantel therapy. At the final evaluation 6 of 6 patients with initial hepatomegaly showed a decrease in liver size.."
I have six questions you need to answer.
Q1: Is this article is about 'human migration mobility': 1 = yes; 0 = no. Answer with a number. Do not give a textual explanation.

Q2: What drivers of migration and mobility does the article study? 0 = 'other', 1 = 'climate', 2 = 'environment', 3 = 'economic', 4 = 'conflict', 5 = 'political', 6 = 'social', 7 = 'family'. Answer with a number or a sequence of numbers separated by commas. Do not give a textual explanation. 

Q3: What is the overall sentiment of the article?:0 = 'neutral', 1 = 'negative', 2 = 'positive'. Answer with a number. Do not give a textual explanation.

Q4: What type of climate or environmental keywords are explicitly mentioned?:  0 = 'none', 1 = 'algal blooms', 2 = 'infestation', 3 = 'infectious diseases', 4 = 'ocean acidification', 5 = 'sea ice', 6 = 'acid rain', 7 = 'drought', 8 = 'cold wave', 9 = 'heat wave', 10 = 'glacial', 11 = 'wildfire', 12 = 'air pollution', 13 = 'biodiversity loss', 14 = 'coastal erosion', 15 = 'land degradation', 16 = 'deforestation', 17 = 'desertification', 18 = 'water pollution', 19 = 'diebacks', 20 = 'permafrost loss', 21 = 'sand mining', 22 = 'sea level rise', 23 = 'earthquake', 24 = 'tsunami', 25 = 'volcanic', 26 = 'flood', 27 = 'avalanche', 28 = 'landslide', 29 = 'downburst', 30 = 'thunderstorm', 31 = 'sandstorm', 32 = 'haze', 33 = 'storm', 34 = 'cyclone', 35 = 'blizzard', 36 = 'hail', 37 = 'snow', 38 = 'tornado', 39 = 'wind', 40 = 'hurricane', 41 = 'typhoon', 42 = 'other'. Answer with a number or a sequence of numbers separated by commas. Do not give a textual explanation. 

Q5: What discipline does the article belong to?: 0 = 'other', 1 = 'social science', 2 = 'natural science', 3 = 'arts and humanities', 4 = 'multidiscipline and interdiscipline'. Answer with a number. Do not give a textual explanation.

Q6: Does the article apply quantitative and/or statistical analysis?: 0 = 'no', 1 = 'yes'. Answer with a number. Do not give a textual explanation.

Use the following template: 

Q1 = [];
Q2 = [];
Q3 = [];
Q4 = [];
Q5 = [];
Q6 = [].<|eot_id|><|start_header_id|>assistant<|end_header_id|>Answer:
Q1 = [0];
Q2 = [];
Q3 = [];
Q4 = [];
Q5 = [0];
Q6 = [1].
TREATMENT OF SCHISTOSOMA-MEKONGI WITH PRAZIQUANTEL - A DOUBLE-BLIND-STUDY
Praziquantel is a newly developed drug effective in the treatment of schistosomiasis. To assess the efficacy and toxicity of praziquantel in the treatment of S. mekongi, 11 infected [human] Laotian refugees, all belonging to a single extended family, were treated in a double-blind crossover trial with praziquantel and placebo. Initially, 1 group of 5 received praziquantel 60 mg/kg body wt in 3 divided doses orally, while the remainder received an identically appearing placebo. Patients were evaluated clinically before, during and following therapy for 2 days. After 2.5 mo. the patients were reevaluated and subjected to the opposite treatment, and final follow-up took place 5-7 mo. later. Three other patients were treated using an open protocol. All but 1 person was cured (91%). This patient failed to show a decrease in egg excretion 2.5 wk after praziquantel therapy and was lost to follow-up thereafter. Side effects were common and consisted primarily of abdominal pain, malaise and fever. These were generaly mild and transient. No abnormal laboratory findings were associated with praziquantel therapy. At the final evaluation 6 of 6 patients with initial hepatomegaly showed a decrease in liver size.